CAS 1206475-79-7 Cyclo(RGDyC) TFA

Send Inquiry
CAS 1206475-79-7 Cyclo(RGDyC) TFA
Details
•CAS Number: 1206475-79-7
•Synonyms: c(RGDyC) TFA; Cyclo(Arg-Gly-Asp-D-Tyr-Cys) trifluoroacetate
•Amino Acid Sequence: cyclo(Arg-Gly-Asp-D-Tyr-Cys) (one-letter: c(RGDyC))
•Peptide Length: 5 amino acids (head-to-tail cyclized, containing D-tyrosine and free cysteine thiol)
•Purity (HPLC): ≥95%
•Salt Form: Trifluoroacetate (TFA)
Related Documents
•Certificate of Analysis (COA)
•Mass Spectrometry (MS) Report
•HPLC Purity Report
•Peptide Solubility and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 1206475-79-7 cyclo(rgdyc) tfa in China, also supports custom service. Welcome to wholesale bulk high quality cas 1206475-79-7 cyclo(rgdyc) tfa from our factory. Contact us for more details.

 

Description Cyclo(RGDyC) TFA is a head-to-tail cyclized pentapeptide with the sequence c(RGDyC), in which tyrosine is in the D-configuration and cysteine carries a free thiol group. This peptide is a classic integrin αvβ3 ligand containing the RGD (Arg-Gly-Asp) integrin recognition motif, capable of specifically binding integrin αvβ3 receptors that are highly expressed on tumor vascular endothelial cells and various tumor cell surfaces. Compared to linear RGD peptides, the cyclized conformation significantly improves binding affinity and selectivity for integrin αvβ3. D-tyrosine enhances the peptide's resistance to proteolytic degradation. The free thiol of cysteine can be covalently linked to drugs, fluorescent probes, nanoparticles, or liposome carriers via maleimide-thiol conjugation. Cyclo(RGDyC) exhibits anti-angiogenic activity and can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer targeted therapy.
Molecular formula C₂₄H₃₄N₈O₈S·xC₂HF₃O₂ (TFA salt)
Molecular weight (Da) 594.64 (free base)
Structure type Cyclic peptide (head-to-tail cyclized, containing D-Tyr and free Cys thiol, integrin targeting)
Solubility Freely soluble in water, PBS, DMSO
Storage Condition Powder at -20°C, dry and protected from light (avoid oxidation)

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Cyclo(RGDyC) TFA Cyclic RGDyC peptide TFA salt; cysteine-modified cyclic RGD peptide Integrin antagonist, tumor-targeting peptide, thiol-conjugatable ligand, tumor imaging Disulfide-cyclized RGD pentapeptide containing D-tyrosine and cysteine residues; the RGD sequence specifically binds integrin αvβ₃, and the free thiol of cysteine can be used for site-specific conjugation of drugs, imaging agents and nanocarriers. C₂₈H₄₂N₈O₈S₂·xTFA 692.28 (free peptide) ~693.0 (free peptide) Trifluoroacetate (TFA) 5 (cyclic pentapeptide)

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-CRGDYC White powder Store at -20°C, sealed, dry and protected from light, under inert gas. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; protect from oxygen during shipping. Stable for 7 days at 4°C. TFA salt is readily soluble in water, dilute acetic acid and PBS. Free cysteine thiol is sensitive to oxygen and metal ions; prone to oxidation and disulfide formation. Avoid combination with oxidants and heavy metals. Stable for 2 years at -20°C, dry, protected from light and under inert gas.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-CRGDYC Cyclic RGDyC peptide with dual integrin targeting and thiol site-specific conjugation Cyclo(RGDyC) is a bifunctional cyclic RGD targeting peptide. Disulfide cyclization stabilizes the RGD active conformation, binding with high affinity and specificity to integrin αvβ₃ overexpressed on tumor vasculature. The cysteine residue provides a free thiol reactive site for site-specific conjugation of chemotherapeutics, fluorescent imaging agents, nanoparticles and hydrogels via disulfide bonds or maleimide addition. Tumor targeted therapy, tumor molecular imaging, targeted drug development, anti-angiogenesis research, nanocarrier targeting modification Integrin αvβ₃; cysteine thiol conjugation site; RGD competitive antagonism

 

 

 

 

Hot Tags: cas 1206475-79-7 cyclo(rgdyc) tfa, China cas 1206475-79-7 cyclo(rgdyc) tfa manufacturers, suppliers, factory, 997-20-6, CAS 191936 91 1, CAS 997 20 6, NGR peptide, therapeutic and pharmaceutical peptides, Transportan

Send Inquiry